The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation.
Good
M F
MF
Kumar
S
S
Miller
L H
LH
D000818:Animals; D000940:Antigenic Variation; D000953:Antigens, Protozoan / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D008288:Malaria / Q000276:immunology / Q000517:prevention & control*; D051379:Mice; D010963:Plasmodium falciparum / Q000235:genetics / Q000254:growth & development / Q000276:immunology*; D014612:Vaccines / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*
D000953:Antigens, Protozoan; D014612:Vaccines; D014614:Vaccines, Synthetic